Comprehensive and personalized system for autonomous T1D management
Diabeloop is a French independent company developing disruptive
technological innovations to automate the treatment of Type one
diabetes.
Its first product, the DBLG1 System, is an integrated
system that allows glycemic control in an automatic and highly efficient
way. The core of this innovation is an Artificial Intelligence hosted
on a terminal that connects via bluetooth with a continuous glucose
meter (CGM) and an insulin pump.
The algorithm makes and executes
the many therapeutic decisions that the patients currently have to
handle by themselves. Patients are only expected to log meals and
physical activities.
• E-healthcare
• Medical devices
• Therapeutic innovation
• Artificial intelligence